title: Efficacy of hematopoietic stem cell transplantation and prophylactic triple intrathecal therapy in a child with multiple CNS relapse of acute lymphoblastic leukemia.
authors.forename: Betul
authors.initials: B
authors.lastname: Tavil
authors.forename: Ali
authors.initials: A
authors.lastname: Ayçicek
authors.forename: Fatih
authors.initials: F
authors.lastname: Azik
authors.forename: Bahattin
authors.initials: B
authors.lastname: Tunc
authors.forename: Buket Erer
authors.initials: BE
authors.lastname: Del Castello
authors.forename: Duygu
authors.initials: D
authors.lastname: Uçkan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000556:secondary / Q000628:therapy*; D002648:Child; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D016572:Cyclosporine / Q000627:therapeutic use*; D005047:Etoposide / Q000008:administration & dosage; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007278:Injections, Spinal; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000517:prevention & control*; D009367:Neoplasm Staging; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate
chemical_list: D007166:Immunosuppressive Agents; D005047:Etoposide; D016572:Cyclosporine; D008727:Methotrexate